HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang Ma Selected Research

cerivastatin (Kazak)

11/2017The burden and correlates of hypertension among Chinese rural population in Han, Uygur, and Kazak: a cross-sectional study.
1/2017Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China.
1/2014Prevalence, awareness, treatment and control of dyslipidemia among adults in northwestern China: the cardiovascular risk survey.
11/2012[Prevalence and associated factors of diabetes mellitus in children of Han, Uigurs and Kazaks ethnicities in Xinjiang].
11/2010[Prevalence of peripheral arterial disease and its correlative risk factors in Xinjiang Uygur and Kazak adult populations].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang Ma Research Topics

Disease

63Neoplasms (Cancer)
12/2022 - 10/2005
17Coronary Artery Disease (Coronary Atherosclerosis)
03/2022 - 10/2013
17Hepatocellular Carcinoma (Hepatoma)
12/2019 - 06/2006
16Stomach Neoplasms (Stomach Cancer)
05/2022 - 09/2014
12Neoplasm Metastasis (Metastasis)
01/2021 - 07/2010
12Hypertension (High Blood Pressure)
08/2020 - 12/2010
12Myocardial Infarction
01/2020 - 01/2002
10Carcinogenesis
01/2021 - 12/2014
9Inflammation (Inflammations)
01/2021 - 09/2004
7Coronary Disease (Coronary Heart Disease)
03/2022 - 01/2011
6Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2022 - 10/2005
6Obesity
01/2022 - 12/2010
6Hypoxia (Hypoxemia)
11/2021 - 01/2018
6Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 01/2009
6Atherosclerosis
09/2019 - 11/2010
5Insulin Resistance
01/2022 - 12/2013
5Hemorrhage
01/2021 - 06/2019
5Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 01/2016
5Infections
12/2018 - 01/2008
4Aortic Dissection
01/2022 - 01/2020
4Anaphylaxis (Anaphylactic Shock)
01/2022 - 01/2017
4Stroke (Strokes)
05/2020 - 11/2010
4Breast Neoplasms (Breast Cancer)
03/2018 - 09/2009
3Diabetes Mellitus
01/2022 - 11/2012
3Hyperandrogenism
01/2022 - 01/2013
3Macular Degeneration (Age-Related Maculopathy)
12/2021 - 10/2008
3Fibrosis (Cirrhosis)
12/2021 - 11/2017
3Acute Coronary Syndrome
11/2021 - 11/2014
3Asthma (Bronchial Asthma)
08/2021 - 11/2010
3Wounds and Injuries (Trauma)
04/2021 - 05/2002
3Melanoma (Melanoma, Malignant)
02/2021 - 09/2011
3Osteosarcoma (Osteogenic Sarcoma)
01/2020 - 01/2019
3Thrombosis (Thrombus)
01/2020 - 01/2013
3Corneal Neovascularization
03/2005 - 12/2003
2Glaucoma
07/2022 - 10/2021
2Respiratory Sounds (Crackle)
01/2022 - 01/2017
2Pneumonia (Pneumonitis)
01/2022 - 12/2018
2Retinal Degeneration
01/2022 - 01/2021
2Choroidal Neovascularization
12/2021 - 01/2019
2Dyslipidemias (Dyslipidemia)
11/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
05/2022 - 10/2005
13Pharmaceutical PreparationsIBA
12/2021 - 06/2012
13MicroRNAs (MicroRNA)IBA
01/2021 - 02/2016
11LipidsIBA
11/2021 - 01/2011
11CholesterolIBA
11/2019 - 11/2010
10Long Noncoding RNAIBA
01/2022 - 06/2015
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 12/2010
7oxidized low density lipoproteinIBA
11/2021 - 02/2015
7Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2016
7Chelating AgentsIBA
10/2018 - 04/2008
7Triglycerides (Triacylglycerol)IBA
01/2018 - 11/2010
6Retinaldehyde (Retinal)IBA
01/2022 - 01/2019
6IronIBA
01/2021 - 04/2008
6Small Interfering RNA (siRNA)IBA
12/2019 - 10/2008
5Cisplatin (Platino)FDA LinkGeneric
10/2019 - 01/2016
5Liposomes (Liposome)IBA
07/2018 - 01/2014
5cerivastatin (Kazak)FDA Link
11/2017 - 11/2010
4Peptides (Polypeptides)IBA
03/2022 - 01/2017
4CollagenIBA
11/2021 - 04/2008
4LigandsIBA
01/2020 - 01/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 09/2004
4CytokinesIBA
01/2019 - 04/2008
4CateninsIBA
01/2017 - 01/2015
4Serum Amyloid A Protein (Serum Amyloid A)IBA
12/2013 - 11/2010
4HDL LipoproteinsIBA
04/2012 - 11/2010
3Insulin (Novolin)FDA Link
01/2022 - 12/2018
3AndrogensIBA
01/2022 - 01/2013
3Epinephrine (Adrenaline)FDA LinkGeneric
01/2022 - 01/2017
3LDL CholesterolIBA
11/2021 - 04/2017
3Lipase (Acid Lipase)FDA Link
11/2021 - 11/2014
3Blood Glucose (Blood Sugar)IBA
01/2021 - 12/2010
3Erythromycin (Erycette)FDA LinkGeneric
11/2020 - 10/2012
3Uric Acid (Urate)IBA
08/2020 - 01/2012
3Untranslated RNA (Noncoding RNA)IBA
08/2020 - 12/2014
3Apolipoprotein A-I (Apolipoprotein A1)IBA
03/2020 - 11/2010
3TransferasesIBA
01/2020 - 01/2019
3Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 01/2018
3DNA (Deoxyribonucleic Acid)IBA
11/2019 - 01/2008
3Therapeutic UsesIBA
05/2019 - 10/2018
3AntibodiesIBA
12/2018 - 01/2005
3MetalsIBA
01/2018 - 01/2008
3EnzymesIBA
01/2017 - 01/2009
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
11/2016 - 12/2003
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
09/2014 - 07/2010
3prostacyclin synthetase (prostacyclin synthase)IBA
03/2009 - 01/2009
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
03/2022 - 09/2019
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2022 - 01/2021
2Fibrillin-1IBA
01/2022 - 01/2022
2Testosterone (Sustanon)FDA Link
01/2022 - 12/2013
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 01/2022
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
01/2022 - 11/2017
2VLDL LipoproteinsIBA
12/2021 - 01/2019

Therapy/Procedure

24Therapeutics
01/2022 - 01/2008
11Percutaneous Coronary Intervention
01/2022 - 01/2013
8Drug Therapy (Chemotherapy)
01/2021 - 09/2011
4Gastrectomy
01/2020 - 01/2016
3Stents
09/2021 - 01/2013
3Radiotherapy
01/2019 - 01/2008
3Radioimmunotherapy
11/2008 - 01/2008
2Lasers (Laser)
12/2021 - 01/2019